Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Certara

Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Certara Launches Phoenix™ Version 8.5 Drug Development Software
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Second Quarter 2024 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
From Certara
Via GlobeNewswire
Tickers CERT
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in the Jefferies Global Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Appoints New Chief Human Resources Officer & General Counsel
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports First Quarter 2024 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Fourth Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
From Certara
Via GlobeNewswire
Tickers CERT
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Third Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Tickers CERT
Certara Simcyp™ Group Awarded Two New Grants from US FDA
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Second Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Participate in the Jefferies Global Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports First Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
From Certara
Via GlobeNewswire
Tickers CERT
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
From Certara
Via GlobeNewswire
Tickers CERT
A.I. Coming to Certara’s D360 Scientific Informatics Software
From Certara
Via GlobeNewswire
Tickers CERT
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
From Certara
Via GlobeNewswire
Tickers CERT
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
Certara Announces Transition Plan for Chief Financial Officer
From Certara
Via GlobeNewswire
Tickers CERT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.